Cargando…
Investigatory pathway and principles of patient selection for epilepsy surgery candidates: a systematic review
BACKGROUND: The predominant treatment for epilepsy is pharmacotherapy, yet 20–40% do not respond to anti-epileptic drugs. After becoming pharmacoresistant, some patients are worked-up to determine candidacy for epilepsy surgery. Despite the 2009 American Epilepsy Society guidelines, there is no broa...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079385/ https://www.ncbi.nlm.nih.gov/pubmed/32183734 http://dx.doi.org/10.1186/s12883-020-01680-w |